https://pbs.twimg.com/media/FhhTdp8XkAEBL2L.png
Warren et al. TYK2i deucravacitinib in plaque psoriasis at 2 years. Sustained efficacy. No new safety signals seen. @RheumNow #ACR22 Abstr#2134 https://t.co/5SGKKrvwbc https://t.co/ynvfZiOrsp

Links:

Deucravacitinib Long-term Efficacy and Safety in Plaque Psoriasis: 2-Year Resul… https://acrabstracts.org/abstract/deucravacitinib-long-term-efficacy-and-safety…
Richard Conway
RichardPAConway
14-11-2022
×